• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ST 段抬高型心肌梗死患者梗死严重程度结局的时间趋势:一项心脏磁共振成像研究。

Temporal Trends in Infarct Severity Outcomes in ST-Segment-Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study.

机构信息

University Clinic of Internal Medicine III, Cardiology and Angiology Medical University of Innsbruck Innsbruck Austria.

University Clinic of Radiology Medical University of Innsbruck Innsbruck Austria.

出版信息

J Am Heart Assoc. 2023 Aug;12(15):e028932. doi: 10.1161/JAHA.122.028932. Epub 2023 Jul 25.

DOI:10.1161/JAHA.122.028932
PMID:37489726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10492996/
Abstract

Background Severity of myocardial tissue injury is a main determinant of morbidity and death related to ST-segment-elevation myocardial infarction (STEMI). Temporal trends of infarct characteristics at the myocardial tissue level have not been described. This study sought to assess temporal trends in infarct characteristics through a comprehensive assessment by cardiac magnetic resonance imaging at a standardized time point early after STEMI. Methods and Results We analyzed patients with STEMI treated with percutaneous coronary intervention at the University Hospital of Innsbruck who underwent cardiac magnetic resonance imaging between 2005 and 2021. The study period was divided into terciles. Myocardial damage characteristics were assessed using a multiparametric cardiac magnetic resonance imaging protocol within the first week after STEMI and compared between groups. A total of 843 patients with STEMI (17% women) with a median age of 57 (interquartile range, 51-66) years were analyzed. While age, sex, and the clinical risk profile expressed as thrombolysis in myocardial infarction risk score were comparable across the study period, there were differences in guideline-recommended therapies. At the same time, there was no significant change in infarct size (=0.25), microvascular obstruction (=0.50), and intramyocardial hemorrhage (=0.34). Left ventricular remodeling indices and left ventricular ejection fraction remained virtually unchanged (all >0.05). Major adverse cardiovascular events at 4 (interquartile range, 4-5) months were similar between groups (=0.36). Conclusions In this magnetic resonance imaging study investigating patients with STEMI treated with primary percutaneous coronary intervention over the past 15 years, no change in infarct severity at the myocardial level has been observed. Clinical research on novel therapeutic approaches to reduce myocardial tissue injury should be a priority.

摘要

背景

心肌组织损伤的严重程度是与 ST 段抬高型心肌梗死(STEMI)相关发病率和死亡率的主要决定因素。心肌组织水平上梗死特征的时间趋势尚未描述。本研究旨在通过在 STEMI 后早期的标准化时间点进行心脏磁共振成像(CMR)综合评估来评估梗死特征的时间趋势。

方法和结果

我们分析了在因 STEMI 接受经皮冠状动脉介入治疗的因斯布鲁克大学医院接受 CMR 检查的患者。研究期间分为三分位数。在 STEMI 后第一周内使用多参数 CMR 成像方案评估心肌损伤特征,并在组间进行比较。共分析了 843 例 STEMI 患者(17%为女性),中位年龄为 57 岁(四分位距,51-66 岁)。虽然整个研究期间年龄、性别和以心肌梗死溶栓治疗风险评分表示的临床风险特征相似,但指南推荐的治疗方法存在差异。与此同时,梗死面积(=0.25)、微血管阻塞(=0.50)和心肌内出血(=0.34)没有显著变化。左心室重构指数和左心室射血分数几乎没有变化(均>0.05)。4 个月(四分位距,4-5 个月)时主要不良心血管事件在各组之间相似(=0.36)。

结论

在这项对过去 15 年接受直接经皮冠状动脉介入治疗的 STEMI 患者进行的磁共振成像研究中,心肌水平的梗死严重程度没有变化。应优先开展针对减少心肌组织损伤的新型治疗方法的临床研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b53a/10492996/5524cef11467/JAH3-12-e028932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b53a/10492996/a37e7fa620d4/JAH3-12-e028932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b53a/10492996/0a80c7c6d71a/JAH3-12-e028932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b53a/10492996/d95c87add23e/JAH3-12-e028932-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b53a/10492996/5524cef11467/JAH3-12-e028932-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b53a/10492996/a37e7fa620d4/JAH3-12-e028932-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b53a/10492996/0a80c7c6d71a/JAH3-12-e028932-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b53a/10492996/d95c87add23e/JAH3-12-e028932-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b53a/10492996/5524cef11467/JAH3-12-e028932-g001.jpg

相似文献

1
Temporal Trends in Infarct Severity Outcomes in ST-Segment-Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study.ST 段抬高型心肌梗死患者梗死严重程度结局的时间趋势:一项心脏磁共振成像研究。
J Am Heart Assoc. 2023 Aug;12(15):e028932. doi: 10.1161/JAHA.122.028932. Epub 2023 Jul 25.
2
Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.ST 段抬高型心肌梗死伴多支血管病变患者完全血运重建与罪犯病变血运重建的比较:DANAMI-3-PRIMULTI 心脏磁共振子研究。
JACC Cardiovasc Interv. 2019 Apr 22;12(8):721-730. doi: 10.1016/j.jcin.2019.01.248.
3
[Predictive value of cardiac magnetic resonance imaging for adverse left ventricular remodeling after acute ST-segment elevation myocardial infarction].[心脏磁共振成像对急性ST段抬高型心肌梗死左心室不良重构的预测价值]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Mar 20;44(3):553-562. doi: 10.12122/j.issn.1673-4254.2024.03.17.
4
Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).半剂量阿替普酶与直接经皮冠状动脉介入治疗在 ST 段抬高型心肌梗死中的疗效和安全性:EARLY-MYO 试验(阿替普酶溶栓后早期常规冠状动脉造影与急性 ST 段抬高型心肌梗死直接经皮冠状动脉介入治疗的比较)。
Circulation. 2017 Oct 17;136(16):1462-1473. doi: 10.1161/CIRCULATIONAHA.117.030582. Epub 2017 Aug 27.
5
Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.在接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者中,左心室肥厚与梗死面积增加及心肌挽救率降低相关。
J Am Heart Assoc. 2017 Jan 9;6(1):e004823. doi: 10.1161/JAHA.116.004823.
6
Predictors of Intramyocardial Hemorrhage After Reperfused ST-Segment Elevation Myocardial Infarction.再灌注治疗的 ST 段抬高型心肌梗死患者心肌内出血的预测因素。
J Am Heart Assoc. 2017 Aug 15;6(8):e005651. doi: 10.1161/JAHA.117.005651.
7
Cardiac magnetic resonance for the early prediction of reverse left ventricular remodeling in patients with ST-segment elevation myocardial infarction.心脏磁共振在 ST 段抬高型心肌梗死患者中预测左心室逆重构的早期应用
Eur Radiol. 2023 Dec;33(12):8501-8512. doi: 10.1007/s00330-023-09907-3. Epub 2023 Jul 17.
8
Left ventricular functional recovery of infarcted and remote myocardium after ST-segment elevation myocardial infarction (METOCARD-CNIC randomized clinical trial substudy).ST段抬高型心肌梗死后梗死心肌和远隔心肌的左心室功能恢复(METOCARD-CNIC随机临床试验子研究)
J Cardiovasc Magn Reson. 2020 Jun 11;22(1):44. doi: 10.1186/s12968-020-00638-8.
9
The Dynamic Relationship Between Invasive Microvascular Function and Microvascular Injury Indicators, and Their Association With Left Ventricular Function and Infarct Size at 1-Month After Reperfused ST-Segment-Elevation Myocardial Infarction.再灌注性ST段抬高型心肌梗死后1个月时,有创微血管功能与微血管损伤指标之间的动态关系及其与左心室功能和梗死面积的关联
Circ Cardiovasc Interv. 2022 Nov;15(11):892-902. doi: 10.1161/CIRCINTERVENTIONS.122.012081. Epub 2022 Oct 28.
10
Aortic Stiffness and Infarct Healing in Survivors of Acute ST-Segment-Elevation Myocardial Infarction.急性 ST 段抬高型心肌梗死幸存者的主动脉僵硬与梗死愈合。
J Am Heart Assoc. 2020 Feb 4;9(3):e014740. doi: 10.1161/JAHA.119.014740. Epub 2020 Jan 31.

引用本文的文献

1
Prognostic role of angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with acute myocardial infarction.1型血管紧张素II受体和A型内皮素-1受体激动性自身抗体在急性心肌梗死患者中的预后作用
Front Cardiovasc Med. 2025 Aug 12;12:1515693. doi: 10.3389/fcvm.2025.1515693. eCollection 2025.
2
Apelin-to-total cholesterol ratio predicts long-term major adverse cardiovascular events in ST-elevation myocardial infarction patients after primary percutaneous coronary intervention: a retrospective cohort analysis.阿佩林与总胆固醇比值可预测ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后的长期主要不良心血管事件:一项回顾性队列分析
BMC Cardiovasc Disord. 2025 Jul 4;25(1):478. doi: 10.1186/s12872-025-04949-5.
3

本文引用的文献

1
Impact of Intramyocardial Hemorrhage on Clinical Outcomes in ST-Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.心肌内出血对ST段抬高型心肌梗死临床结局的影响:一项系统评价和Meta分析。
J Soc Cardiovasc Angiogr Interv. 2022 Aug 26;1(6):100444. doi: 10.1016/j.jscai.2022.100444. eCollection 2022 Nov-Dec.
2
Evolution of Myocardial Tissue Injury: A CMR Study Over a Decade After STEMI.心肌组织损伤的演变:ST段抬高型心肌梗死十年后的心脏磁共振成像研究
JACC Cardiovasc Imaging. 2022 Jun;15(6):1030-1042. doi: 10.1016/j.jcmg.2022.02.010. Epub 2022 May 11.
3
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.
The prognostic and therapeutic significance of polyunsaturated fatty acid-derived oxylipins in ST-segment elevation myocardial infarction.多不饱和脂肪酸衍生的氧化脂质在ST段抬高型心肌梗死中的预后和治疗意义。
Imeta. 2025 Jan 9;4(1):e266. doi: 10.1002/imt2.266. eCollection 2025 Feb.
4
CAESAR lives on with IMPACT: bringing rigor and relevance to cardioprotection research.“恺撒”与“影响”计划携手共进:为心脏保护研究带来严谨性与实用性。
Basic Res Cardiol. 2024 Dec;119(6):889-892. doi: 10.1007/s00395-024-01082-w. Epub 2024 Oct 18.
5
The Role of Microvascular Obstruction and Intra-Myocardial Hemorrhage in Reperfusion Cardiac Injury. Analysis of Clinical Data.微血管阻塞和心肌内出血在再灌注性心脏损伤中的作用。临床数据分析。
Rev Cardiovasc Med. 2024 Mar 14;25(3):105. doi: 10.31083/j.rcm2503105. eCollection 2024 Mar.
6
Association of Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Agonistic Autoantibodies With Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction.1型血管紧张素II受体和A型内皮素-1受体激动性自身抗体与急性心肌梗死后不良重塑和心血管事件的关联
J Am Heart Assoc. 2024 Feb 20;13(4):e032672. doi: 10.1161/JAHA.123.032672. Epub 2024 Feb 13.
心肌梗死后左心室重构:病理生理学、影像学及新疗法
Eur Heart J. 2022 Jul 14;43(27):2549-2561. doi: 10.1093/eurheartj/ehac223.
4
Transitional changes in the structure of C-reactive protein create highly pro-inflammatory molecules: Therapeutic implications for cardiovascular diseases.C-反应蛋白结构的转变产生高度促炎分子:对心血管疾病的治疗意义。
Pharmacol Ther. 2022 Jul;235:108165. doi: 10.1016/j.pharmthera.2022.108165. Epub 2022 Mar 3.
5
Intramyocardial Hemorrhage: The Final Frontier for Preventing Heart Failure Post-Myocardial Infarction.心肌内出血:预防心肌梗死后心力衰竭的最后前沿阵地。
J Am Coll Cardiol. 2022 Jan 4;79(1):49-51. doi: 10.1016/j.jacc.2021.11.002.
6
Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study.COVID-19 大流行限制措施对 ST 段抬高型心肌梗死的影响:一项心脏磁共振成像研究。
Eur Heart J. 2022 Mar 14;43(11):1141-1153. doi: 10.1093/eurheartj/ehab621.
7
Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018.2003 年至 2018 年 ST 段抬高型心肌梗死患者特征和结局的时间变化。
Catheter Cardiovasc Interv. 2021 May 1;97(6):1109-1117. doi: 10.1002/ccd.28901. Epub 2020 Apr 15.
8
Role of Cardiac Magnetic Resonance to Improve Risk Prediction Following Acute ST-Elevation Myocardial Infarction.心脏磁共振成像在改善急性ST段抬高型心肌梗死风险预测中的作用
J Clin Med. 2020 Apr 7;9(4):1041. doi: 10.3390/jcm9041041.
9
Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015.根据再灌注治疗的使用情况,ST 段抬高型心肌梗死患者的特征、治疗和结局二十年变化趋势:来自 FAST-MI 项目 1995-2015 年的数据。
Am Heart J. 2019 Aug;214:97-106. doi: 10.1016/j.ahj.2019.05.007. Epub 2019 May 16.
10
Evaluation of Microvascular Injury in Revascularized Patients With ST-Segment-Elevation Myocardial Infarction Treated With Ticagrelor Versus Prasugrel.替格瑞洛与普拉格雷治疗 ST 段抬高型心肌梗死血运重建患者的微血管损伤评估。
Circulation. 2019 Jan 29;139(5):636-646. doi: 10.1161/CIRCULATIONAHA.118.035931.